Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21561347

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 May 12
First author
Conroy T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Aug 25;365(8):768-9; author reply 769. doi: 10.1056/NEJMc1107627.
    note
    Source null
    related pmid
    21864184
    relationship
    Comment in
  2. citation
    Natl Med J India. 2011 Nov-Dec;24(6):356-7.
    note
    Source null
    related pmid
    22680261
    relationship
    Comment in

Authors and identifiers

  1. name
    Conroy T
    type
    Author
  2. name
    Desseigne F
    type
    Author
  3. name
    Ychou M
    type
    Author
  4. name
    Bouché O
    type
    Author
  5. name
    Guimbaud R
    type
    Author
  6. name
    Bécouarn Y
    type
    Author
  7. name
    Adenis A
    type
    Author
  8. name
    Raoul JL
    type
    Author
  9. name
    Gourgou-Bourgade S
    type
    Author
  10. name
    de la Fouchardière C
    type
    Author
  11. name
    Bennouna J
    type
    Author
  12. name
    Bachet JB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Conroy T
    type
    Author
  2. name
    Desseigne F
    type
    Author
  3. name
    Ychou M
    type
    Author
  4. name
    Bouché O
    type
    Author
  5. name
    Guimbaud R
    type
    Author
  6. name
    Bécouarn Y
    type
    Author
  7. name
    Adenis A
    type
    Author
  8. name
    Raoul JL
    type
    Author
  9. name
    Gourgou-Bourgade S
    type
    Author
  10. name
    de la Fouchardière C
    type
    Author
  11. name
    Bennouna J
    type
    Author
  12. name
    Bachet JB
    type
    Author
bibliography ids
  1. nci-bib-da5844c2cc65e1a3e19e4797
book metadata
content sha256
52f3b93eb8e02d0a2fe57660ef8af7f16baab470ff78b596755a077d4a45512b
document type
citation
dois
  1. 10.1056/NEJMoa1011923
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:21561347
immutable id
pubmed:21561347@52f3b93eb8e02d0a2fe57660ef8af7f16baab470ff78b596755a077d4a45512b
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1817-25
volume
364
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Aug 25;365(8):768-9; author reply 769. doi: 10.1056/NEJMc1107627.
    note
    Source null
    related pmid
    21864184
    relationship
    Comment in
  2. citation
    Natl Med J India. 2011 Nov-Dec;24(6):356-7.
    note
    Source null
    related pmid
    22680261
    relationship
    Comment in
outcomes validated
false
pmid
21561347
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
a42e37cbebcd4fa934d5ed6e0dffd1db308e966b3ed0d72e64a2a2c3d24d381f
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 May 12
precision
day
year
2011
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21561347/
title
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Preserved source evidence · Not medical advice